Stay updated with breaking news from Gusto Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COMPANY NEWS: HR platform for global distributed workforces, Remote, has launched its first-to-market API solution in Australia, in a bid to help busi...
Global Microbiome Therapeutics and Diagnostics Market
RESEARCH TRIANGLE PARK - Healthy microbiome developed by a Triangle biotech startup that targets inflammatory diseases shows promise as a "breakthrough" therapy
Washington [US], May 30 (ANI): A new study published in Nature Communications demonstrates that a consortium of bacteria designed to complement missing or underrepresented functions in the imbalanced microbiome of inflammatory bowel disease (IBD) patients, prevented and treated chronic immune-mediated colitis in humanized mouse models.
A new study published in Nature Communications demonstrates that a consortium of bacteria designed to complement missing or underrepresented functions in the imbalanced microbiome of inflammatory bowel disease (IBD) patients, prevented and treated chronic immune-mediated colitis in humanized mouse models.